Curative timed NK cell-based immunochemotherapy aborts brain tumour recurrence driven by mesenchymal glioma stem cells
Brian Meehan, Lata Adnani, Xianbing Zhu, Nadim Tawil, Delphine Garnier, Ichiro Nakano, Sidong Huang, Janusz Rak
Springer Nature ·
2025-03-21
· DOI 10.1186/s40478-025-01984-3
The publisher did not provide an abstract — full text is available via the link below.
Brian Meehan, Lata Adnani, Xianbing Zhu, Nadim Tawil, Delphine Garnier, Ichiro Nakano et al. Curative timed NK cell-based immunochemotherapy aborts brain tumour recurrence driven by mesenchymal glioma stem cells. // Acta Neuropathologica Communications. – 2025. – DOI: 10.1186/s40478-025-01984-3. – URL: https://doi.org/10.1186/s40478-025-01984-3
Brian Meehan, Lata Adnani, Xianbing Zhu, Nadim Tawil, Delphine Garnier, Ichiro Nakano, Sidong Huang, & Janusz Rak (2025). Curative timed NK cell-based immunochemotherapy aborts brain tumour recurrence driven by mesenchymal glioma stem cells. Acta Neuropathologica Communications. https://doi.org/10.1186/s40478-025-01984-3
Brian Meehan, et al. “Curative timed NK cell-based immunochemotherapy aborts brain tumour recurrence driven by mesenchymal glioma stem cells.” Acta Neuropathologica Communications, 2025. doi:10.1186/s40478-025-01984-3.
@article{Meehan2025,
title = {Curative timed NK cell-based immunochemotherapy aborts brain tumour recurrence driven by mesenchymal glioma stem cells},
author = {Meehan, Brian and Adnani, Lata and Zhu, Xianbing and Tawil, Nadim and Garnier, Delphine and Nakano, Ichiro and Huang, Sidong and Rak, Janusz},
journal = {Acta Neuropathologica Communications},
year = {2025},
doi = {10.1186/s40478-025-01984-3},
url = {https://doi.org/10.1186/s40478-025-01984-3}
}